The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Waiting time for results dramatically reduces when sample analysis happens in health facilities rather than centralised labs – but increased viral loads often go unaddressed
Study among teenagers living with HIV in Johannesburg finds 9% have a mental health issue – and are more likely to be virally unsuppressed than others
Study of young South Africans living with HIV finds a third have experienced violence and a similar proportion are depressed – but those with support and self-esteem are less likely to suffer
Study calls for increased testing of STIs, in place of diagnosing based on symptoms alone, as many young Zimbabweans with an STI present with zero symptoms.
A study suggests vaginal bacteria may be playing an underestimated role in PrEP efficacy for women
National data from five Southern African countries suggests nearly 89% of adults on HIV treatment are virally suppressed – but gaps remain.
Malawians in some rural areas face travel times to HIV clinics that are almost double others’ journeys.
Evidence review suggests enhanced testing services, which offer things such as counselling or support groups, are having little impact on condom use.
UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.